Tradestie Institutional Equity Comparison Engine
COCP vs STTK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
STTK Overall Edge
STTK Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shattuck Labs, Inc. Common Stock (STTK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus STTK at N/M Forward P/E and 0.0% operating margin (-66.6% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
COCP N/M vs STTK N/M Fwd P/E
Growth & Margin Winner
STTK
Op Margin -3063.6% vs 0.0% ยท YoY +26.9% vs -66.6%
Momentum & Technical Winner
STTK
1Y -3.0% vs +147.8% ยท 52W Pos 19% vs 43%
Options & Structure Winner
STTK
UNCLASSIFIED (N/A IV) vs BREAKDOWN (10th %ile IV)
COCP
NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap
$19.6M
1M Return
-2.01%
1Y Return
-2.96%
Forward P/E
N/M
Unified AI Score
47.1 / 100
HOLD
Tech 51.0
Fund 48.0
Flow 50.0
Mom 54.0
STTK
NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.56
-1.94% 1D
Market Cap
$474.6M
1M Return
-15.87%
1Y Return
+147.83%
Forward P/E
N/M
Unified AI Score
51.1 / 100
HOLD
Tech 48.0
Fund 58.0
Flow 63.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
COCP -2.96%
STTK +147.83%
Spread: +150.79 pp (STTK Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | COCP Revenue | STTK Revenue | COCP Op. Margin | STTK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2011 | $10M | N/A | -30.6% | N/A | COCP |
| FY2019 | $10M | $10M | -737.4% | -253.5% | STTK |
| FY2020 | $0M | $10M | -476.0% | -371.8% | STTK |
| FY2021 | N/A | $30M | N/A | -150.8% | STTK |
| FY2022 | N/A | $0M | N/A | -15848.0% | STTK |
| FY2023 | N/A | $0M | N/A | -5549.6% | STTK |
| FY2024 | N/A | $10M | N/A | -1408.3% | STTK |
| FY2025 | N/A | $0M | N/A | -5150.8% | STTK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COCP | STTK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $474.6M | Larger Scale | STTK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +26.9% | -66.6% | Higher Growth | COCP |
| Operating Margin (TTM) Profitability | -3063.6% | 0.0% | Higher Margin | STTK |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -311.7% | -47.2% | Higher ROE | STTK |
| 52-Week Range Position Momentum | 19% ($1โ$2) | 43% ($2โ$8) | Stronger Trend | STTK |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 54% Vol | 1.48ฮฒ ยท 78% Vol | Lower Realized Risk | COCP |
| Unified Institutional Score Composite Signal | 47.1 / 100 (HOLD) | 51.1 / 100 (HOLD) | Higher Composite | STTK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full COCP vs STTK Buy Guide
COCP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
STTK
BREAKDOWN
58d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither COCP nor STTK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.